Literature DB >> 14732848

[Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region].

Corinne Bonny1, Romain Rayssiguier, Sylvie Ughetto, Bruno Aublet-Cuvelier, Jacques Baranger, Gérard Blanchet, Jacques Delteil, Philippe Hautefeuille, Françoise Lapalus, Patrick Montanier, Gilles Bommelaer, Armand Abergel.   

Abstract

AIMS: To determine the medical practices and expectations of general practitioners concerning screening and management of hepatitis C in the Auvergne region.
METHODS: A survey was sent by mail to 250 general practitioners. They were then contacted by telephone interviews.
RESULTS: 94% of general practitioners answered the survey. Each physician diagnosed an average of 0.6 new cases of hepatitis C in 1999, and had a mean of 3.2 patients with HCV in their practice. Screening was performed by 91% of general practitioners if there was a history of blood transfusion, by 87% if there was a history of intravenous drug use, by 92% in case of increased serum amino transferase levels. Screening was less frequent in case of household contact and was only performed by 68% general practitioners or of asthenia by 52% of general practitioners. Liver biopsy seems to be the main obstacle for the management of hepatitis C patients which is due to a refusal of liver biopsy by the patient according to 55% of general practitioners, a fear of complications according to 25% of general practitioners. Sixty percent of general practitioners considered that liver biopsy was performed in less than 50% of patients with hepatitis C. Fifty three percent of general practitioner thought that hepatitis C network could be useful for increasing their knowledge.
CONCLUSIONS: Liver biopsy refusal by the patient restricts the management and therapy of patients with hepatitis C infection. Increase formation still requisite by 60 percent of general practitioner.

Entities:  

Mesh:

Year:  2003        PMID: 14732848

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  13 in total

1.  Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.

Authors:  Hong Koh; Seung Kim; Myung-Joon Kim; Hyun Gi Kim; Hyun Joo Shin; Mi-Jung Lee
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

2.  Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.

Authors:  Giada Sebastiani; Alessandro Vario; Maria Guido; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  Management of liver cirrhosis between primary care and specialists.

Authors:  Ignazio Grattagliano; Enzo Ubaldi; Leonilde Bonfrate; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

4.  Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Authors:  Shawky Abdelhamid Fouad; Serag Esmat; Dalia Omran; Laila Rashid; Mohamed H Kobaisi
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

5.  Quantitative detection of cirrhosis: towards the development of computer-assisted detection method.

Authors:  Hannu T Huhdanpaa; Peng Zhang; Venkataramu N Krishnamurthy; Chris Douville; Binu Enchakolody; Chris Chou; Sampathkumar Ethiraj; Stewart Wang; Grace L Su
Journal:  J Digit Imaging       Date:  2014-10       Impact factor: 4.056

6.  Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Authors:  Giada Sebastiani; Peter Ghali; Phil Wong; Marina B Klein; Marc Deschenes; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2014-01

Review 7.  Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Authors:  Giada Sebastiani; Alfredo Alberti
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 8.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 9.  Chronic hepatitis C and liver fibrosis.

Authors:  Giada Sebastiani; Konstantinos Gkouvatsos; Kostas Pantopoulos
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.

Authors:  Giada Sebastiani
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.